Schonfeld Strategic Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-98,274
| Closed | -$2.8M | – | 2079 |
|
|
2024
Q3 | $2.8M | Buy |
98,274
+76,047
| +342% | +$2.17M | 0.02% | 633 |
|
|
2024
Q2 | $587K | Buy |
+22,227
| New | +$587K | ﹤0.01% | 1294 |
|
|
2023
Q3 | – | Sell |
-55,475
| Closed | -$1.05M | – | 1842 |
|
|
2023
Q2 | $1.05M | Buy |
55,475
+17,813
| +47% | +$338K | 0.01% | 935 |
|
|
2023
Q1 | $584K | Sell |
37,662
-64,123
| -63% | -$995K | 0.01% | 1107 |
|
|
2022
Q4 | $1.81M | Sell |
101,785
-15,639
| -13% | -$278K | 0.02% | 861 |
|
|
2022
Q3 | $656K | Buy |
+117,424
| New | +$656K | 0.01% | 1532 |
|
|
2021
Q4 | – | Sell |
-24,400
| Closed | -$212K | – | 2148 |
|
|
2021
Q3 | $212K | Sell |
24,400
-25,600
| -51% | -$222K | ﹤0.01% | 1653 |
|
|
2021
Q2 | $529K | Sell |
50,000
-5,303
| -10% | -$56.1K | 0.01% | 1121 |
|
|
2021
Q1 | $887K | Buy |
55,303
+36,674
| +197% | +$588K | 0.01% | 909 |
|
|
2020
Q4 | $860K | Sell |
18,629
-26,283
| -59% | -$1.21M | 0.01% | 825 |
|
|
2020
Q3 | $1.58M | Buy |
44,912
+10,512
| +31% | +$370K | 0.03% | 542 |
|
|
2020
Q2 | $837K | Buy |
+34,400
| New | +$837K | 0.02% | 618 |
|
|
2020
Q1 | – | Sell |
-85,000
| Closed | -$1.35M | – | 1312 |
|
|
2019
Q4 | $1.35M | Buy |
+85,000
| New | +$1.35M | 0.03% | 424 |
|